Global Fluralaner API Market Growth 2025-2031

Global Fluralaner API Market Growth 2025-2031

The global Fluralaner API market size is predicted to grow from US$ 79 million in 2025 to US$ 104 million in 2031; it is expected to grow at a CAGR of 4.7% from 2025 to 2031.

Fluralaner, isoxazoline class compound, is a systemic insecticide and acaricide with antiparasitic activity against cat and dog fleas and ticks. Fluralaner is an inhibitor of the arthropod nervous system. Fluralaner inhibits γ-aminobutyric acid (GABA)-gated chloride channels (GABACls) and L-glutamate-gated chloride channels (GluCls). Potency of fluralaner is comparable to fipronil (a phenylpyrazole ectoparasiticide). Fluralaner API in this report.

Global key manufacturers of Fluralaner API include Nissan Chemical, Hikal, Hubei Masteam Bio-tech, Jiangsu Rivocean, Shaanxi Dideu, etc. Global top five manufacturers hold a share about 85%. Asia-Pacific is the largest market of Fluralaner API, holds a share over 35%. In terms of product, purity above 98% ones hold a larger segment, with a share over 75%. And in terms of application, the largest application is oral drug, with a share of over 70%.

LP Information, Inc. (LPI) ' newest research report, the “Fluralaner API Industry Forecast” looks at past sales and reviews total world Fluralaner API sales in 2024, providing a comprehensive analysis by region and market sector of projected Fluralaner API sales for 2025 through 2031. With Fluralaner API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Fluralaner API industry.

This Insight Report provides a comprehensive analysis of the global Fluralaner API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Fluralaner API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Fluralaner API market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Fluralaner API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Fluralaner API.

This report presents a comprehensive overview, market shares, and growth opportunities of Fluralaner API market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Purity above 98%
Purity below 98%

Segmentation by Application:
Oral Drug
Topical Drug

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Nissan Chemical
Hikal
Hubei Masteam Bio-tech
Jiangsu Rivocean
Shaanxi Dideu
Zhejiang Gihi Chemicals
Hunan Huateng Pharmaceutical
Taizhou Crene Biotechnology

Key Questions Addressed in this Report

What is the 10-year outlook for the global Fluralaner API market?

What factors are driving Fluralaner API market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Fluralaner API market opportunities vary by end market size?

How does Fluralaner API break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.